HPDI Table of Contents Vol. 13, No. 3, 2014

October 2014
Digestive Surgery;Oct2014, Vol. 31 Issue 3, p243
Academic Journal
No abstract available


Related Articles

  • Neutrophil-lymphocyte rations may predict HCC recurrence in liver transplant recipients.  // Hem/Onc Today;11/10/2012, Vol. 13 Issue 21, p23 

    The article reports on the results of a study concerning the rate of recurrence on patients with hepatocellular carcinoma who had neutrophil-lymphocyte ratios of 4 or greater following a liver transplant.

  • Longer transplant waits for HCC patients may be beneficial.  // Hem/Onc Today;12/10/2013, Vol. 14 Issue 23, p23 

    The article discusses a research study which suggested the benefit of longer transplant waits for patients with hepatocellular carcinoma (HCC), presented at The Liver Meeting held in Washington on November 1-5, 2013.

  • HBPD Table of Contents, Vol. 16, No. 6, 2017.  // Digestive Surgery;Feb2018, Vol. 35 Issue 2, p179 

    No abstract available.

  • OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. Vasuri, Francesco; Golfieri, Rita; Fiorentino, Michelangelo; Capizzi, Elisa; Renzulli, Matteo; Pinna, Antonio; Grigioni, Walter; D'Errico-Grigioni, Antonia; Pinna, Antonio D; Grigioni, Walter F // Virchows Archiv;Aug2011, Vol. 459 Issue 2, p141 

    The organic anion transporter peptides (OATP) 1B1 and 1B3 are hepatocytic-specific transporters determinant for the uptake of the contrast media Gd-EOB-DTPA during magnetic resonance, but variably lost in hepatocellular carcinoma (HCC). Here, we studied a series of HCCs from livers that...

  • Surgical aspects of liver disease.  // GP: General Practitioner;4/7/2003, p60 

    This article focuses on the recommendations made by physician Keith Barnard on various web pages at gponline.com. The web site addresswww.livercancer.com/index.html is from the Liver Cancer Network, a project supported by Allgheny General Hospital(General Hospital) in Pennsylvania. the web site...

  • O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Zhu, Qianqian; Zhou, Lin; Yang, Zhe; Lai, Mingchun; Xie, Haiyang; Wu, Liming; Xing, Chunyang; Zhang, Feng; Zheng, Shusen // Medical Oncology;Jun2012, Vol. 29 Issue 2, p985 

    O-linked-ß-N-acetylglucosamine (O-GlcNAc) modification is a crucial post-translational modification. The enzymes responsible for the addition and removal of O-GlcNAc have been identified as O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). In this study, O-GlcNAcylation level was examined in...

  • Hepatocellular carcinoma. Ezaki, T. // BMJ: British Medical Journal (International Edition);1/25/92, Vol. 304 Issue 6821, p196 

    Focuses on hepatocellular carcinoma in Japan. Responsibility of the disease for at least one million death a year; Consideration of five year survival rate after surgical resection; Failure of the results of liver transplantation for the disease.

  • A Fair Chance for Everyone: Total Tumor Volume as a Selection Tool in Liver Transplantation for Hepatocellular Carcinoma. Pinto-Marques, Hugo; Silva, Silvia; Sobral, Mafalda; Perdigoto, Rui; Martins, Américo; Barroso, Eduardo // Digestive Surgery;Oct2018, Vol. 35 Issue 6, p539 

    Total tumor volume (TTV) has been proposed as a more accurate means of selecting patients for liver transplantation (LT) due to hepatocellular carcinoma (HCC). We aim to analyze the role of TTV in a population with a short waiting time on list. Methods: Analysis of a prospective database of...

  • HBPD Table of Contents Vol. 17, Nr. 4, 2018.  // Digestive Surgery;Dec2018, Vol. 36 Issue 1, p93 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics